z-logo
open-access-imgOpen Access
Second-line hormonal therapy with the enzalutamid in patients with castrate-resistant prostate cancer
Author(s) -
Б. Я. Алексеев,
К. М. Нюшко,
А. С. Калпинский,
А. Д. Каприн
Publication year - 2016
Publication title -
onkourologiâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 4
eISSN - 1996-1812
pISSN - 1726-9776
DOI - 10.17650/1726-9776-2016-12-3-87-95
Subject(s) - medicine , docetaxel , prostate cancer , hormonal therapy , oncology , clinical trial , population , disease , cancer , chemotherapy , environmental health

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here